We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00142337
Recruitment Status : Completed
First Posted : September 2, 2005
Last Update Posted : January 6, 2012
Information provided by (Responsible Party):
Marc Lallemant, Institut de Recherche pour le Developpement